Happiness Is A Skill by Brooke Siem

I know, I’ve been gone for a while. Plenty of reasons, including waiting for the results of my Mitome test, a mitochondrial function test developed by Chris Masterjohn, PhD, whose work I’ve been decoding since the beginning of the year.

The following newsletter, and issues 154-158 and 161-162, are a “translation” of Chris Masterjohn, PhD’s work on serotonin and antidepressants. In a world of rampant plagiarism and AI writing, it is important to me that credit is given where credit is due. I want to make it clear to the reader that the bulk of the hypotheses and data in this series are credited to Masterjohn and his noble efforts to untangle the mess we’ve been sold about antidepressants.

The following newsletter references issues 154-158 and 161-162, which are a “translation” of Chris Masterjohn, PhD’s work on serotonin and antidepressants. I will pick up this work in following issues, and encourage you to scroll to the bottom of this newsletter for a summary of each and to catch up before the next issue drops.

The following newsletter, and issues 154-158 and 161, are a “translation” of Chris Masterjohn, PhD’s work on serotonin and antidepressants. In a world of rampant plagiarism and AI writing, it is important to me that credit is given where credit is due. I want to make it clear to the reader that the bulk of the hypotheses and data in this series are credited to Masterjohn and his noble efforts to untangle the mess we’ve been sold about antidepressants.

The following newsletter, and issues 154-158, are a “translation” of Chris Masterjohn, PhD’s work on serotonin and antidepressants. In a world of rampant plagiarism, it is important to me that credit is given where credit is due. I want to make it clear to the reader that the bulk of the hypotheses and data in this series are credited to Masterjohn and his noble efforts to untangle the mess we’ve been sold about antidepressants.

Yesterday, in yet another whiplash moment, the New York Times released the article, “More Teens Are Taking Antidepressants. It Could Disrupt Their Sex Lives for Years,” which focuses on Post SSRI Sexual Dysfunction, a topic with which I am unfortunately, all too familiar. I was surprised by this article because the Times has been particularly wishy washy on the subject of antidepressants over the past year.

Hi everyone. I’m taking a break from working through Chris Masterjohn, PhD’s work on serotonin and SSRIs because I’m going through a sudden breakup and frankly, I’m just not up for it. Instead, I’d like to share a recent roundtable discussion I had with safe deprescribing titans Dr. David Healy, Angie Peacock, David Antonuccio, PhD., and Kim Witzack.

A note from Brooke: The following newsletter, and the four newsletters preceding it, are a “translation” of Chris Masterjohn, PhD’s work on serotonin and antidepressants. In a world of rampant plagiarism, it is important to me that credit is given where credit is due. I want to make it clear to the reader that the bulk of the hypotheses and data in this series are credited to Masterjohn and his noble efforts to untangle the mess we’ve been sold about antidepressants.

We’re working our way through Chris Masterjohn, PhD’s work on how the relationship between serotonin, antidepressants, and our cells creates the perfect storm for antidepressant withdrawal. Masterjohn’s work is dense. And as we get deeper into it, it’s only getting more complex. It makes me feel like a kid being forced to practice piano. I know I need to slow down, pay attention, and go through it again to get better.

We are currently working through Chris Masterjohn, PhD’s 10-part series on serotonin and how its function (and dysfunction) connects to antidepressant withdrawal. Because Masterjohn’s work is dense and aimed at an audience with a significant biological and physiological background, I am taking the time to break down his work and explain it in a way that even we English majors can understand.